120 related articles for article (PubMed ID: 27256336)
1. Effect of Insulin and Metformin Combination Treatment on Colon Adenoma and Advanced Adenoma Among DM II.
Jain D; Chhoda A; Uribe J
J Gastrointest Cancer; 2016 Dec; 47(4):404-408. PubMed ID: 27256336
[TBL] [Abstract][Full Text] [Related]
2. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy.
Kanadiya MK; Gohel TD; Sanaka MR; Thota PN; Shubrook JH
J Diabetes Complications; 2013; 27(5):463-6. PubMed ID: 23755906
[TBL] [Abstract][Full Text] [Related]
3. The effect of quality of segmental bowel preparation on adenoma detection rate.
Guo R; Wang YJ; Liu M; Ge J; Zhang LY; Ma L; Huang WY; Zhai HH
BMC Gastroenterol; 2019 Jul; 19(1):119. PubMed ID: 31286888
[TBL] [Abstract][Full Text] [Related]
4. Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer.
Del Vecchio Blanco G; Cretella M; Paoluzi OA; Caruso A; Mannisi E; Servadei F; Romeo S; Grasso E; Sileri P; Giannelli M; Biancone L; Palmieri G; Pallone F
Colorectal Dis; 2013 Sep; 15(9):1093-9. PubMed ID: 23627814
[TBL] [Abstract][Full Text] [Related]
5. Adenoma detection rate in high-risk patients differs from that in average-risk patients.
Sanaka MR; Rai T; Navaneethan U; Gohel TD; Podugu A; Thota PN; Lopez R; Kiran RP; Burke CA
Gastrointest Endosc; 2016 Jan; 83(1):172-8. PubMed ID: 26024584
[TBL] [Abstract][Full Text] [Related]
6. The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma.
Han MS; Lee HJ; Park SJ; Hong SP; Cheon JH; Kim WH; Kim TI
Int J Colorectal Dis; 2017 Aug; 32(8):1223-1226. PubMed ID: 28210856
[TBL] [Abstract][Full Text] [Related]
7. Importance of reporting segmental bowel preparation scores during colonoscopy in clinical practice.
Jain D; Momeni M; Krishnaiah M; Anand S; Singhal S
World J Gastroenterol; 2015 Apr; 21(13):3994-9. PubMed ID: 25852286
[TBL] [Abstract][Full Text] [Related]
8. Comparison of adenoma detection rate and adenoma per colonoscopy as a quality indicator of colonoscopy.
Park SK; Kim HY; Lee CK; Cha JM; Eun CS; Han DS; Lee BI; Shin JE; Park DI
Scand J Gastroenterol; 2016 Jul; 51(7):886-90. PubMed ID: 27001284
[TBL] [Abstract][Full Text] [Related]
9. Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence.
Delavari A; Bishehsari F; Salimzadeh H; Khosravi P; Delavari F; Nasseri-Moghaddam S; Merat S; Ansari R; Vahedi H; Shahbazkhani B; Saberifiroozi M; Sotoudeh M; Malekzadeh R
BMC Gastroenterol; 2014 Nov; 14():196. PubMed ID: 25404264
[TBL] [Abstract][Full Text] [Related]
10. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
[TBL] [Abstract][Full Text] [Related]
11. Different bowel preparation schedule leads to different diagnostic yield of proximal and nonpolypoid colorectal neoplasm at screening colonoscopy in average-risk population.
Chiu HM; Lin JT; Lee YC; Liang JT; Shun CT; Wang HP; Wu MS
Dis Colon Rectum; 2011 Dec; 54(12):1570-7. PubMed ID: 22067187
[TBL] [Abstract][Full Text] [Related]
12. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus.
Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH
Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944
[TBL] [Abstract][Full Text] [Related]
13. Anatomic and advanced adenoma detection rates as quality metrics determined via natural language processing.
Gawron AJ; Thompson WK; Keswani RN; Rasmussen LV; Kho AN
Am J Gastroenterol; 2014 Dec; 109(12):1844-9. PubMed ID: 24935271
[TBL] [Abstract][Full Text] [Related]
14. Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus?
Cho YH; Ko BM; Kim SH; Myung YS; Choi JH; Han JP; Hong SJ; Jeon SR; Kim HG; Kim JO; Lee MS
Intest Res; 2014 Apr; 12(2):139-45. PubMed ID: 25349581
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
[TBL] [Abstract][Full Text] [Related]
17. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY
PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841
[TBL] [Abstract][Full Text] [Related]
18. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
[TBL] [Abstract][Full Text] [Related]
19. Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costs.
Austin GL; Fennimore B; Ahnen DJ
Am J Gastroenterol; 2013 Mar; 108(3):296-301. PubMed ID: 23208273
[TBL] [Abstract][Full Text] [Related]
20. Impact of bowel preparation on surveillance colonoscopy interval.
Singhal S; Virk MA; Momeni M; Krishnaiah M; Anand S
Scand J Gastroenterol; 2014 Jul; 49(7):885-90. PubMed ID: 24902032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
